Seragon Pharmaceuticals, a multinational leader of pharm innovation and R&D, officially registered its local operation at China World Trade Center in the Central Business District (CBD) area of Beijing on December 11, 2020. The local company Seragon (China) will serve as its Asia-Pacific headquarters, which marks the first case of regional headquarters settlement of multinationals in the China (Beijing) Pilot Free Trade Zone (Beijing FTZ), as well as the formal establishment of enterprise recognition mechanism in the CBD area of the Beijing FTZ.

In recent years, Beijing's CBD has been continuously improving its business environment, and its functional area has attracted more than 10,000 foreign-funded enterprises, including 105 regional headquarters of multinational companies and over 200 Fortune Global 500 enterprises, and now homes more than 65 percent of Beijing's foreign financial institutions and more than 90 percent of international media organizations in Bejing.

Beijing's CBD will center on the development of the integrated national demonstration zone for greater openness in the service sector and Beijing FTZ, leverage on international resources of the district, promote the further opening up and improve the environment for doing business to attract more high-quality enterprises to settle down. The purpose is to serve well the enterprises to promote the high-quality development of the regional economy and strive to build the area into a world-class CBD, according to the Beijing CBD Administration Committee. (Beijing Evening News)